COMPANY · NIPC 516040006

Hemangimed - Tratamento de Patologias Vasculares, Lda

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €37,620 across 2 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameHemangimed - Tratamento de Patologias Vasculares, Lda
NIPC516040006

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2025 to 2026. The table below gives the same values.2025: €18,90020252026: €18,7202026€18,900
Contracted value by year
YearContractsContract value
20251€18,900
20261€18,720
Contracted value by buyer
NameContractsContract value
Unidade Local de Saúde de Lisboa Ocidental, E. P. E.1€18,900
Unidade Local de Saúde de Lisboa Ocidental, EPE1€18,720
Contracted value by place of performance
NameContractsContract value
Lisboa2€37,620
Largest contracts
SubjectYearContract value
167001925 – Aquisição de serviços médicos, em regime de prevenção, durante o ano de 2025 na Cirurgia Vascular da ULSLO, EPE2025€18,900
167001526 – Aquisição de serviços médicos durante o ano de 2026 na Cirurgia Vascular da ULSLO, EPE2026€18,720

Who they competed with

In 2 contracts with a list of competitors, the company took part and was awarded 2 (100%).

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

The documents we read show no links between these companies.

Investigations that mention it

No published investigation mentions this company by NIPC.